News & AnalysisBioterror Research

Panel Endorses Anthrax Vaccine Study in Children

See allHide authors and affiliations

Science  04 Nov 2011:
Vol. 334, Issue 6056, pp. 577
DOI: 10.1126/science.334.6056.577

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Should children be enrolled in a clinical trial of the anthrax vaccine, which is almost certain not to help them and may harm them? Or should the U.S. government gamble and wait for a possible attack before exposing children to the vaccine for the very first time? Last week, the full National Biodefense Science Board voted 12–1 in favor of a trial assuming its ethics are approved by a review board, saying that it was too uneasy to risk a mass science experiment on thousands of children after a bioterror strike, even if some consider that possibility remote.